Related Experiment Videos
Multiple endocrine neoplasia type 1.
1Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, England. rajesh.thakker@ndm.ox.ac.uk
Endocrinology and Metabolism Clinics of North America
|October 18, 2000
Summary
Multiple Endocrine Neoplasia type 1 (MEN-1) is an inherited disorder. Advances in molecular biology now allow for the identification of at-risk carriers for early screening and management of endocrine tumors.
Area of Science:
- Genetics and Molecular Biology
- Endocrinology
- Oncology
Background:
- Multiple Endocrine Neoplasia type 1 (MEN-1) is an autosomal dominant inherited condition.
- Understanding MEN-1 manifestations has improved patient management and screening protocols.
- The MEN1 gene and its protein's role in JunD-mediated transcription are under investigation.
Purpose of the Study:
- To summarize the current understanding of MEN-1, including its genetic basis and clinical features.
- To highlight advancements in molecular biology for identifying MEN-1 gene mutations and carriers.
- To emphasize the importance of screening for early detection of endocrine tumors in at-risk individuals.
Main Methods:
- Review of combined clinical and laboratory investigations.
- Application of molecular biology techniques for gene identification and mutation detection.
- Analysis of the MEN1 gene's protein product and its transcriptional regulatory functions.
Main Results:
- Identification of the MEN1 gene responsible for the disorder.
- Detection of mutations in patients with MEN-1.
- Understanding the role of the MEN1 protein in regulating JunD-mediated transcription.
Conclusions:
- Molecular biology advances enable the identification of individuals carrying MEN1 mutations.
- Early identification of carriers facilitates targeted screening for endocrine tumors.
- Regular biochemical screening is crucial for detecting tumor development in high-risk MEN-1 patients.